For Immediate Release
Media Contact:
Devendra Mishra
Executive Director
Phone: 818-224-1552
BSMA APPOINTS DR. ARUN SIVANANADAM
AS THE CHIEF SCIENCE & INNOVATION OFFICER 
Calabasas, CA May 18, 2021 - BSMA, the premiere global alliance of supply chain management professionals in Life Sciences, has appointed Dr. Arun Sivanandam to serve as the Chief Science and Innovation Officer (CSIO). He will provide strategic direction to ensure that innovative approaches to supply chain challenges of emerging medical science breakthroughs are addressed. In addition, Dr. Sivanandam will be a resource for Conference planning, Bio-Intel Newsletter and the Steering Committees of Clinical and Commercial Supply Chain, Cell and Gene Therapy, and Digital Transformation.

Devendra Mishra, Executive Director of BSMA, observed, “The mission of BSMA is to advance the supply chain which connects Science with Innovation to deliver healthcare. Dr. Arun Sivanandam will provide the foundational knowledge and experience to help design and deliver our programs with a deeper purpose. He will champion transformational opportunities in the supply chain to further blend science with business as CRISPR, Immunotherapy, and disruptive Technologies of AI and Machine Learning are maturing.”

Dr. Arun Sivanandam remarked, “I welcome this opportunity from BSMA to provide strategic insight, foster collaboration among the global supply chain community and drive innovation with intent to provide unique solutions to the problems of our time using the latest cutting-edge approaches. COVID-19 disruption in supply chain has highlighted the importance of managing supply chain logistics with a digitally connected partner ecosystem and rapid adoption of innovation as the key driver to overcoming crises.”
Arun Sivanandam is a Senior Clinical Operations Program Management Consultant leading Gastric Immuno-Oncology Biomarker-based Phase 0 and Phase 1 First-in-Human Innovative Study Design trials globally through COVID-19 regulatory, clinical and supply-chain challenges. In 2019, he served as the Senior Clinical Trial Specialist for Phase 1 and Investigator-Initiated Early Development rare-disease Gastric/Neuroendocrine Oncology trials at the Stanford Cancer Institute.

Earlier, Arun was a Senior Scientific Advisor to the COVID-19 Taskforce of the American Association of Precision Medicine, where he discovered a passion for healthcare innovation and entrepreneurship, along with data science predictive analytics and remote-monitoring models for value-based precision healthcare improvements globally.

Arun Sivanandam has completed a Medical Doctorate at Michigan State University after-which he transitioned into Clinical Research by developing strategic Patient Recruitment models to catapult the Veterans Affairs Loma Linda Medical Center Million Veteran Program Genomics Initiative to the Number 2 spot in the United States within 4 months of joining. He has a bachelor’s degree in Biological Sciences from University of California Riverside while working on Osteoporosis research, and a master’s degree in Biomedical Sciences from Wayne State University. His dissertation focused on molecular mechanisms, intracellular signal transduction and naturopathic anti-tumor effects around the Androgen Receptor in Prostate Cancer at the Vattikutti Urology Institute of Henry Ford Health System. 
About BSMA
BSMA - Driving Innovation in the Life Sciences Supply Chain

Since its inception in 2007, BSMA is a global organization that fosters Innovation and Adoption of disruptive technologies within the end-to-end supply chain of the Life Sciences industry. With offices in California (USA), Brussels (Belgium) and Mumbai (India), BSMA promotes collaboration and networking between professionals of the biotech, pharmaceutical, academic and medical diagnostics enterprises. The Alliance partners with industry, academia, foundations, suppliers, technology enablers, research institutions, trade organizations and the government to improve productivity, quality, product and service integrity, risk mitigation, managerial talent development and patient care globally. It is also the home of start-up companies engaged in business development and scale up.     
CONTACT: Devendra Mishra